Frontlight ResearchEarly access
Trial site
Uniklinik Marburg
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Kidney cancer1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Phase
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Ipsen1 trial
- Replimune, Inc.1 trial
Running trials
Active, not recruiting
Active, not recruiting
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
Site data: ClinicalTrials.govUpdated 12 Nov 2026